XML 13 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 47,281,986 $ 38,524,536
Prepaid research and development contracts 455,855 311,154
Other current assets 1,845,451 734,785
Total current assets 49,583,292 39,570,475
Furniture and equipment, net 137,325 164,187
Operating lease right-of-use assets, net 89,761 162,124
Deposits 20,000 40,000
Total assets 49,830,378 39,936,786
Current liabilities:    
Accounts payable and accrued expenses 2,417,172 3,231,450
Current portion of operating lease liability 94,787 102,555
Total current liabilities 2,511,959 3,334,005
Operating lease liability, net of current portion   67,438
Total liabilities 2,511,959 3,401,443
Commitments and contingencies (Note 9)
Stockholders’ equity:    
Common stock, $0.0001 par value per share; 300,000,000 shares authorized and 47,111,659 and 40,588,004 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively. 4,711 4,059
Additional paid-in capital 189,146,884 178,766,806
Accumulated deficit (141,833,176) (142,235,522)
Total stockholders’ equity 47,318,419 36,535,343
Total liabilities and stockholders’ equity $ 49,830,378 $ 39,936,786